<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="review-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/ms2026-105</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-9968</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ТЕРАПИЯ БОЛИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PAIN THERAPY</subject></subj-group></article-categories><title-group><article-title>Хроническая неспецифическая поясничная боль: причины, диагноз и лечение</article-title><trans-title-group xml:lang="en"><trans-title>Chronic nonspecific low back pain: Causes, diagnosis, and treatment</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1992-7960</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Парфенов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Parfenov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Парфенов Владимир Анатольевич - д.м.н., профессор, заведующий кафедрой нервных болезней Института клинической медицины.</p><p>119048, Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Vladimir А. Parfenov - Dr. Sci. (Med.), Professor, Head of the Department of Nervous Diseases at the Institute of Clinical Medicine, Sechenov First Moscow State Medical University (Sechenov University).</p><p>8, Bldg. 2, Trubetskaya St., Moscow, 119048</p></bio><email xlink:type="simple">vladimirparfenov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Первый Московский государственный медицинский университет имени И.М. Сеченова (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>19</day><month>04</month><year>2026</year></pub-date><volume>0</volume><issue>3</issue><fpage>76</fpage><lpage>81</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Парфенов В.А., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Парфенов В.А.</copyright-holder><copyright-holder xml:lang="en">Parfenov V.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/9968">https://www.med-sovet.pro/jour/article/view/9968</self-uri><abstract><p>Хроническая неспецифическая (скелетно-мышечная) поясничная боль (ХНПБ) представляет одну из наиболее частых причин временной инвалидности и снижения качества жизни. К факторам риска развития НПБ относят тяжелый физический труд, чрезмерные сгибания и разгибания, частые наклоны туловища, подъем тяжестей, а также сидячий образ жизни, вибрационные воздействия. Хроническому течению поясничной боли способствуют не только патологические изменения (поражение межпозвоночного диска, фасеточного сустава, крестцово-подвздошного сочленения, мышц и связок), но и неадекватное лечение острой боли, чрезмерное ограничение физических нагрузок, «болевой» тип личности, тревожные и депрессивные расстройства (социальные и психологические факторы боли). Диагноз ХНПБ основывается на клиническом обследовании, отсутствии признаков опасного заболевания («красные флажки»), радикулопатии и центрального поясничного стеноза. При хронической неспецифической боли в спине (ХНБС) рекомендуется информировать пациента о благоприятном прогнозе заболевания и его факторах риска, необходимости избегать чрезмерных статических и физических нагрузок, неправильных положений и поз, целесообразности сохранения физической, социальной и профессиональной активности. При ХНПБ наиболее эффективен мультимодальный подход, который в качестве нелекарственных методов должен включать образовательную программу, лечебные физические упражнения, мануальную терапию, а также у части пациентов психологические методы терапии. Для уменьшения боли при ХНПБ наиболее часто используются нестероидные противовоспалительные средства (НПВС). Обсуждаются эффективность и профиль безопасности применения при ХНПБ в качестве НПВС эторикоксиба (Аркоксиа) и локальное введение Дипроспана при поражении поясничных фасеточных суставов и пояснично-крестцового сочленения. Для профилактики поясничной боли рекомендуются лечебные упражнения, образовательная программа по избеганию чрезмерных статических и физических нагрузок, неправильных положений и поз.</p></abstract><trans-abstract xml:lang="en"><p>Chronic nonspecific (musculoskeletal) low back pain (CNLBP) is one of the most common causes of temporary disability and decreased quality of life. Risk factors for CNLDP include heavy physical labor, excessive flexion and extension, frequent bending, heavy lifting, a sedentary lifestyle, and exposure to vibration. Chronic low back pain is facilitated not only by pathological changes (damage to the intervertebral disc, facet joint, sacroiliac joint, muscles, and ligaments), but also by inadequate treatment of acute pain, excessive limitation of physical activity, a “pain-prone” personality type, and anxiety and depressive disorders (social and psychological factors of pain). The diagnosis of CNLBP is based on a clinical examination and the absence of signs of dangerous disease (“red flags”), radiculopathy, and spinal stenosis. In chronic lower back pain, it is recommended to inform the patient about the favorable prognosis of the disease and its risk factors, the need to avoid excessive static and physical stress, incorrect positions and postures, and the advisability of maintaining physical, social, and professional activity. A multimodal approach is most effective in chronic lower back pain, which, as non-drug methods, should include an educational program, therapeutic physical exercises, manual therapy, and, for some patients, psychological therapy methods. Non-steroidal anti-inflammatory drugs (NSAIDs) are most often used to reduce pain in chronic lower back pain. The efficacy and safety of etoricoxib (Arcoxia) as an NSAID and local administration of Diprospan for lesions of the lumbar facet joints and lumbosacral articulation are discussed. To prevent low back pain, therapeutic exercises and an educational program on avoiding excessive static and physical stress, incorrect positions and postures are recommended.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническая неспецифическая поясничная боль</kwd><kwd>нестероидные противовоспалительные средства</kwd><kwd>эторикоксиб</kwd><kwd>Аркоксиа</kwd><kwd>Дипроспан</kwd><kwd>кинезиотерапия</kwd><kwd>комплексное (мультимодальное) лечение хронической боли</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic nonspecific low back pain</kwd><kwd>nonsteroidal anti-inflammatory drugs</kwd><kwd>etoriskoxib</kwd><kwd>Arcoxia</kwd><kwd>diprospan</kwd><kwd>kinesiotherapy</kwd><kwd>complex (multimodal) treatment of chronic pain</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ferrari AJ, Santomauro DF, Aali A, Abate YH, Abbafati C, Abbastabar H et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133–2161. https://doi.org/10.1016/S0140-6736(24)00757-8.</mixed-citation><mixed-citation xml:lang="en">Ferrari AJ, Santomauro DF, Aali A, Abate YH, Abbafati C, Abbastabar H et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133–2161. https://doi.org/10.1016/S0140-6736(24)00757-8.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ferreira ML, Luca K, Haile LM, Steinmetz JD, Culbreth GT, Cross M et al. GBD 2021 Low Back Pain Collaborators. Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(6):e316–e329. https://doi.org/10.1016/S2665-9913(23)00098-X.</mixed-citation><mixed-citation xml:lang="en">Ferreira ML, Luca K, Haile LM, Steinmetz JD, Culbreth GT, Cross M et al. GBD 2021 Low Back Pain Collaborators. Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(6):e316–e329. https://doi.org/10.1016/S2665-9913(23)00098-X.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tavee JO, Levin KH. Low Back Pain. Continuum. 2017;23(2):467–486. https://doi.org/10.1212/CON.0000000000000449.</mixed-citation><mixed-citation xml:lang="en">Tavee JO, Levin KH. Low Back Pain. Continuum. 2017;23(2):467–486. https://doi.org/10.1212/CON.0000000000000449.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Maher C, Underwood M, Buchbinder R. Non-specific low back pain. Lancet. 2017;389(10070):736–747. https://doi.org/10.1016/S0140-6736(16)30970-9.</mixed-citation><mixed-citation xml:lang="en">Maher C, Underwood M, Buchbinder R. Non-specific low back pain. Lancet. 2017;389(10070):736–747. https://doi.org/10.1016/S0140-6736(16)30970-9.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Парфенов ВА, Исайкин АИ. Боли в поясничной области. М.; 2018. 200 с. Режим доступа: https://www.elibrary.ru/pbhsux.</mixed-citation><mixed-citation xml:lang="en">Парфенов ВА, Исайкин АИ. Боли в поясничной области. М.; 2018. 200 с. Режим доступа: https://www.elibrary.ru/pbhsux.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Stevans JM, Delitto A, Khoja SS, Patterson CG, Smith CN, Schneider MJ et al. Risk Factors Associated With Transition From Acute to Chronic Low Back Pain in US Patients Seeking Primary Care. JAMA Netw Open. 2021;4(2):e2037371. https://doi.org/10.1001/jamanetworkopen.2020.37371.</mixed-citation><mixed-citation xml:lang="en">Stevans JM, Delitto A, Khoja SS, Patterson CG, Smith CN, Schneider MJ et al. Risk Factors Associated With Transition From Acute to Chronic Low Back Pain in US Patients Seeking Primary Care. JAMA Netw Open. 2021;4(2):e2037371. https://doi.org/10.1001/jamanetworkopen.2020.37371.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Головачева ВА, Головачева АА, Таршилова АР. Хроническая скелетно-мышечная боль в спине: ошибки при ведении пациентов и вопросы оптимизации. Неврология, нейропсихиатрия, психосоматика. 2024;16(3):103–109. https://doi.org/10.14412/2074-2711-2024-3-103-109.</mixed-citation><mixed-citation xml:lang="en">Golovacheva VA, Golovacheva AA, Tarshilova AR. Chronic musculoskeletal low back pain: mistakes in patient management and optimization issues. Neurology, Neuropsychiatry, Psychosomatics. 2024;16(3):103–109. (In Russ.) https://doi.org/10.14412/2074-2711-2024-3-103-109.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Головачева АА, Головачева ВА. Комплексное лечение пациентов с хронической неспецифической болью в спине и коморбидными нарушениями: проспективное клиническое исследование. Неврология, нейропсихиатрия, психосоматика. 2024;16(6):45–52. https://doi.org/10.14412/2074-2711-2024-6-45-52.</mixed-citation><mixed-citation xml:lang="en">Golovacheva AA, Golovacheva VA. Complex treatment of patients with chronic non-specific back pain and comorbid disorders: a prospective clinical study. Neurology, Neuropsychiatry, Psychosomatics. 2024;16(6):45–52. (In Russ.) https://doi.org/10.14412/2074-2711-2024-6-45-52.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Головачева АА, Табеева ГР. Хроническая неспецифическая боль в спине в сочетании с головной болью напряжения, вопросы оптимизации терапии. Неврология, нейропсихиатрия, психосоматика. 2025;17(2):55–62. https://doi.org/10.14412/2074-2711-2025-2-55-62.</mixed-citation><mixed-citation xml:lang="en">Golovacheva AA, Tabeeva GR. Chronic non-specific low back pain in combination with tension-type headache, issues of therapy optimization. Neurology, Neuropsychiatry, Psychosomatics. 2025;17(2):55–62. (In Russ.) https://doi.org/10.14412/2074-2711-2025-2-55-62.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hung C-I, Liu C-Y, Fu T-S. Depression: an important factor associated with disability among patients with chronic low back pain. Int J Psychiatry Med. 2015;49:187–198. https://doi.org/10.1177/0091217415573937.</mixed-citation><mixed-citation xml:lang="en">Hung C-I, Liu C-Y, Fu T-S. Depression: an important factor associated with disability among patients with chronic low back pain. Int J Psychiatry Med. 2015;49:187–198. https://doi.org/10.1177/0091217415573937.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Wertli MM, Eugster R, Held U, Steurer J, Kofmehl R, Weiser S. Catastrophizing – a prognostic factor for outcome in patients with low back pain: A systematic review. Spine J. 2014;14(11):2639–2657. https://doi.org/10.1016/j.spinee.2014.03.003.</mixed-citation><mixed-citation xml:lang="en">Wertli MM, Eugster R, Held U, Steurer J, Kofmehl R, Weiser S. Catastrophizing – a prognostic factor for outcome in patients with low back pain: A systematic review. Spine J. 2014;14(11):2639–2657. https://doi.org/10.1016/j.spinee.2014.03.003.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Stubbs B, Koyanagi A, Thompson T, Veronese N, Carvalho AF, Solomi M et al. The epidemiology of back pain and its relationship with depression, psychosis, anxiety, sleep disturbances, and stress sensitivity: Data from 43 low- and middle-income countries. Gen Hosp Psychiatry. 2016;43:63–70. https://doi.org/10.1016/j.genhosppsych.2016.09.008.</mixed-citation><mixed-citation xml:lang="en">Stubbs B, Koyanagi A, Thompson T, Veronese N, Carvalho AF, Solomi M et al. The epidemiology of back pain and its relationship with depression, psychosis, anxiety, sleep disturbances, and stress sensitivity: Data from 43 low- and middle-income countries. Gen Hosp Psychiatry. 2016;43:63–70. https://doi.org/10.1016/j.genhosppsych.2016.09.008.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Jenkins HJ, Hancock MJ, Maher CG, French SD, Magnussen JS. Understanding patient beliefs regarding the use of imaging in the management of low back pain. Eur J Pain. 2016;20(4):573–580. https://doi.org/10.1002/ejp.764.</mixed-citation><mixed-citation xml:lang="en">Jenkins HJ, Hancock MJ, Maher CG, French SD, Magnussen JS. Understanding patient beliefs regarding the use of imaging in the management of low back pain. Eur J Pain. 2016;20(4):573–580. https://doi.org/10.1002/ejp.764.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kamper SJ, Apeldoorn AT, Chiarotto A, Smeets RJ, Ostelo RW, Guzman J, van Tulder MW. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain. Cochrane Database Syst Rev. 2014;(9):CD000963. https://doi.org/10.1002/14651858.CD000963.pub3.</mixed-citation><mixed-citation xml:lang="en">Kamper SJ, Apeldoorn AT, Chiarotto A, Smeets RJ, Ostelo RW, Guzman J, van Tulder MW. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain. Cochrane Database Syst Rev. 2014;(9):CD000963. https://doi.org/10.1002/14651858.CD000963.pub3.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Jurak I, Delaš K, Erjavec L, Stare J, Locatelli I. Effects of Multidisciplinary Biopsychosocial Rehabilitation on Short-Term Pain and Disability in Chronic Low Back Pain: A Systematic Review with Network Meta-Analysis. J Clin Med. 2023;12(23):7489. https://doi.org/10.3390/jcm12237489.</mixed-citation><mixed-citation xml:lang="en">Jurak I, Delaš K, Erjavec L, Stare J, Locatelli I. Effects of Multidisciplinary Biopsychosocial Rehabilitation on Short-Term Pain and Disability in Chronic Low Back Pain: A Systematic Review with Network Meta-Analysis. J Clin Med. 2023;12(23):7489. https://doi.org/10.3390/jcm12237489.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Rizzo RR, Cashin AG, Wand BM, Ferraro MC, Sharma S, Lee H et al. Non-pharmacological and non-surgical treatments for low back pain in adults: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2025;(3):CD014691. https://doi.org/10.1002/14651858.CD014691.pub2.</mixed-citation><mixed-citation xml:lang="en">Rizzo RR, Cashin AG, Wand BM, Ferraro MC, Sharma S, Lee H et al. Non-pharmacological and non-surgical treatments for low back pain in adults: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2025;(3):CD014691. https://doi.org/10.1002/14651858.CD014691.pub2.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Hernandez-Lucas P, Leirós-Rodríguez R, Lopez-Barreiro J, García-Soidán JL. Is the combination of exercise therapy and health education more effective than usual medical care in the prevention of non-specific back pain? A systematic review with meta-analysis. Ann Med. 2022;54(1):3107–3116. https://doi.org/10.1080/07853890.2022.2140453.</mixed-citation><mixed-citation xml:lang="en">Hernandez-Lucas P, Leirós-Rodríguez R, Lopez-Barreiro J, García-Soidán JL. Is the combination of exercise therapy and health education more effective than usual medical care in the prevention of non-specific back pain? A systematic review with meta-analysis. Ann Med. 2022;54(1):3107–3116. https://doi.org/10.1080/07853890.2022.2140453.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Ochsenkuehn FR, Crispin A, Weigl MB. Chronic low back pain: a prospective study with 4 to 15 years follow-up after a multidisciplinary biopsychosocial rehabilitation program. BMC Musculoskelet Disord. 2022;23(1):977. https://doi.org/10.1186/s12891-022-05963-w.</mixed-citation><mixed-citation xml:lang="en">Ochsenkuehn FR, Crispin A, Weigl MB. Chronic low back pain: a prospective study with 4 to 15 years follow-up after a multidisciplinary biopsychosocial rehabilitation program. BMC Musculoskelet Disord. 2022;23(1):977. https://doi.org/10.1186/s12891-022-05963-w.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Corp N, Mansell G, Stynes S, Wynne-Jones G, Morsø L, Hill JC et al. Evidence-based treatment recommendations for neck and low back pain across Europe: A systematic review of guidelines. Eur J Pain. 2020;25:275–295. https://doi.org/10.1002/ejp.1679.</mixed-citation><mixed-citation xml:lang="en">Corp N, Mansell G, Stynes S, Wynne-Jones G, Morsø L, Hill JC et al. Evidence-based treatment recommendations for neck and low back pain across Europe: A systematic review of guidelines. Eur J Pain. 2020;25:275–295. https://doi.org/10.1002/ejp.1679.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y, Yan L, Hou L, Zhang X, Zhao H, Yan C et al. Exercise intervention for patients with chronic low back pain: a systematic review and network meta-analysis. Front Public Health. 2023;11:1155225. https://doi.org/10.3389/fpubh.2023.1155225.</mixed-citation><mixed-citation xml:lang="en">Li Y, Yan L, Hou L, Zhang X, Zhao H, Yan C et al. Exercise intervention for patients with chronic low back pain: a systematic review and network meta-analysis. Front Public Health. 2023;11:1155225. https://doi.org/10.3389/fpubh.2023.1155225.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Hendrick P, Te Wake AM, Tikkisetty AS, Wulff L, Yap C, Milosavljevic S. The effectiveness of walking as an intervention for low back pain: a systematic review. Eur Spine J. 2010;19(10):1613–1620. https://doi.org/10.1007/s00586-010-1412-z.</mixed-citation><mixed-citation xml:lang="en">Hendrick P, Te Wake AM, Tikkisetty AS, Wulff L, Yap C, Milosavljevic S. The effectiveness of walking as an intervention for low back pain: a systematic review. Eur Spine J. 2010;19(10):1613–1620. https://doi.org/10.1007/s00586-010-1412-z.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Miyamoto GC, Lin CWC, Cabral CMN, van Dongen JM, van Tulder MW. Cost-effectiveness of exercise therapy in the treatment of nonspecific neck pain and low back pain: a systematic review with meta-analysis. Br J Sports Med. 2019;53(3):172–181. https://doi.org/10.1136/bjsports-2017-098765.</mixed-citation><mixed-citation xml:lang="en">Miyamoto GC, Lin CWC, Cabral CMN, van Dongen JM, van Tulder MW. Cost-effectiveness of exercise therapy in the treatment of nonspecific neck pain and low back pain: a systematic review with meta-analysis. Br J Sports Med. 2019;53(3):172–181. https://doi.org/10.1136/bjsports-2017-098765.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Calafiore D, Marotta N, Longo UG, Vecchio M, Zito R, Lippi L et al. The efficacy of manual therapy and therapeutic exercise for reducing chronic non-specific neck pain: A systematic review and meta-analysis. J Back Musculoskelet Rehabil. 2025;38(3):407–419. https://doi.org/10.1177/10538127241304110.</mixed-citation><mixed-citation xml:lang="en">Calafiore D, Marotta N, Longo UG, Vecchio M, Zito R, Lippi L et al. The efficacy of manual therapy and therapeutic exercise for reducing chronic non-specific neck pain: A systematic review and meta-analysis. J Back Musculoskelet Rehabil. 2025;38(3):407–419. https://doi.org/10.1177/10538127241304110.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain. London: National Institute for Health and Care Excellence (NICE); 2021. 164 p. Available at: https://www.nice.org.uk/guidance/ng193/evidence/i-manual-therapy-for-chronic-primary-pain-pdf-326591532180.</mixed-citation><mixed-citation xml:lang="en">Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain. London: National Institute for Health and Care Excellence (NICE); 2021. 164 p. Available at: https://www.nice.org.uk/guidance/ng193/evidence/i-manual-therapy-for-chronic-primary-pain-pdf-326591532180.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Pinto RZ, Maher CG, Ferreira ML, Ferreira PH, Hancock M, Oliveira VC et al. Drugs for relief of pain in patients with sciatica: systematic review and meta-analysis. BMJ. 2012;344:e497. https://doi.org/10.1136/bmj.e497.</mixed-citation><mixed-citation xml:lang="en">Pinto RZ, Maher CG, Ferreira ML, Ferreira PH, Hancock M, Oliveira VC et al. Drugs for relief of pain in patients with sciatica: systematic review and meta-analysis. BMJ. 2012;344:e497. https://doi.org/10.1136/bmj.e497.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Machado GC, Maher CG, Ferreira PH, Day RO, Pinheiro MB, Ferreira ML. Non-steroidal anti-inflammatory drugs for spinal pain: a systematic review and meta-analysis. Ann Rheum Dis. 2017;76(7):1269–1278. https://doi.org/10.1136/annrheumdis-2016-210597.</mixed-citation><mixed-citation xml:lang="en">Machado GC, Maher CG, Ferreira PH, Day RO, Pinheiro MB, Ferreira ML. Non-steroidal anti-inflammatory drugs for spinal pain: a systematic review and meta-analysis. Ann Rheum Dis. 2017;76(7):1269–1278. https://doi.org/10.1136/annrheumdis-2016-210597.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Enthoven WT, Roelofs PD, Deyo RA, van Tulder MW, Koes BW. Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database Syst Rev. 2016;(2):CD012087. https://doi.org/10.1002/14651858.cd012087.</mixed-citation><mixed-citation xml:lang="en">Enthoven WT, Roelofs PD, Deyo RA, van Tulder MW, Koes BW. Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database Syst Rev. 2016;(2):CD012087. https://doi.org/10.1002/14651858.cd012087.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Каратеев АЕ. Эторикоксиб может использоваться при неспецифической боли в спине: новое показание для хорошо известного препарата. Неврология, нейропсихиатрия, психосоматика. 2020;12(2):125–130. https://doi.org/10.14412/2074-2711-2020-2-125-130.</mixed-citation><mixed-citation xml:lang="en">Karateev AE. Etoricoxib can be used for chronic nonspecific back pain: a new indication of the well-known drug. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(2):125–130. (In Russ.) https://doi.org/10.14412/2074-2711-2020-2-125-130.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Birbara CA, Puopolo AD, Munoz DR, Sheldon EA, Mangione A., Bohidar NR et al. Treatment of chronic low back pain with etoricoxib, a new cyclooxy-genase-2 selective inhibitor: improvement in pain and disability – a randomized, placebo-controlled, 3-month trial. J Pain. 2003;4(6):307–315. https://doi.org/10.1016/s1526-5900(03)00633-3.</mixed-citation><mixed-citation xml:lang="en">Birbara CA, Puopolo AD, Munoz DR, Sheldon EA, Mangione A., Bohidar NR et al. Treatment of chronic low back pain with etoricoxib, a new cyclooxy-genase-2 selective inhibitor: improvement in pain and disability – a randomized, placebo-controlled, 3-month trial. J Pain. 2003;4(6):307–315. https://doi.org/10.1016/s1526-5900(03)00633-3.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Pallay RM, Seger W, Adler JL. Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial. Scand J Rheumatol. 2004;33:257–266. https://doi.org/10.1080/03009740410005728.</mixed-citation><mixed-citation xml:lang="en">Pallay RM, Seger W, Adler JL. Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial. Scand J Rheumatol. 2004;33:257–266. https://doi.org/10.1080/03009740410005728.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Zerbini C, Ozturk ZE, Grifka J. Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4-week, multinational, randomized, double-blind study. Curr Med Res Opin. 2005;21:2037–2049. https://doi.org/10.1185/030079905x75069.</mixed-citation><mixed-citation xml:lang="en">Zerbini C, Ozturk ZE, Grifka J. Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4-week, multinational, randomized, double-blind study. Curr Med Res Opin. 2005;21:2037–2049. https://doi.org/10.1185/030079905x75069.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">da Costa BR, Pereira TV, Saadat P, Rudnicki M, Iskander SM, Bodmer NS et al. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis. BMJ. 2021;375:n2321. https://doi.org/10.1136/bmj.n2321.</mixed-citation><mixed-citation xml:lang="en">da Costa BR, Pereira TV, Saadat P, Rudnicki M, Iskander SM, Bodmer NS et al. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis. BMJ. 2021;375:n2321. https://doi.org/10.1136/bmj.n2321.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Jiao YiP, Yong QiS, Ke Chun G, Xing YuL, Ze Zhong L, Jin Shuai D et al. Assessing the efficacy and safety of different nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis: A systematic review and network meta-analysis based on RCT trials. PLoS ONE. 2025;20(5):e0320379. https://doi.org/10.1371/journal.pone.0320379.</mixed-citation><mixed-citation xml:lang="en">Jiao YiP, Yong QiS, Ke Chun G, Xing YuL, Ze Zhong L, Jin Shuai D et al. Assessing the efficacy and safety of different nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis: A systematic review and network meta-analysis based on RCT trials. PLoS ONE. 2025;20(5):e0320379. https://doi.org/10.1371/journal.pone.0320379.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Moss P, Benson HAE, Will R, Wright A. Fourteen days of Etoricoxib 60 Mg improves pain, hyperalgesia and physical function in individuals with knee osteoarthritis: a randomized controlled trial. Osteoarthritis Cartilage. 2017;25(11):1781–1791. https://doi.org/10.1016/j.joca.2017.07.009.</mixed-citation><mixed-citation xml:lang="en">Moss P, Benson HAE, Will R, Wright A. Fourteen days of Etoricoxib 60 Mg improves pain, hyperalgesia and physical function in individuals with knee osteoarthritis: a randomized controlled trial. Osteoarthritis Cartilage. 2017;25(11):1781–1791. https://doi.org/10.1016/j.joca.2017.07.009.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Arendt-Nielsen L, Egsgaard LL, Petersen KK. Evidence for a central mode of action for etoricoxib (COX-2 inhibitor) in patients with painful knee osteoarthritis. Pain. 2016;157:1634–1644. https://doi.org/10.1097/j.pain.0000000000000562.</mixed-citation><mixed-citation xml:lang="en">Arendt-Nielsen L, Egsgaard LL, Petersen KK. Evidence for a central mode of action for etoricoxib (COX-2 inhibitor) in patients with painful knee osteoarthritis. Pain. 2016;157:1634–1644. https://doi.org/10.1097/j.pain.0000000000000562.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Manchikanti L, Abdi S, Atluri S, Benyamin RM, Boswell MV, Buenaventura RM et al. An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part II: guidance and recommendations. Pain Physician. 2013;16(2 Suppl.):S49–S283. Available at: https://pubmed.ncbi.nlm.nih.gov/23615883.</mixed-citation><mixed-citation xml:lang="en">Manchikanti L, Abdi S, Atluri S, Benyamin RM, Boswell MV, Buenaventura RM et al. An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part II: guidance and recommendations. Pain Physician. 2013;16(2 Suppl.):S49–S283. Available at: https://pubmed.ncbi.nlm.nih.gov/23615883.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Kaye AD, Brouillette AE, Howe CA, Wajid S, Archer JR, Bartolina R et al. Efficacy of Steroid Facet Joint Injections for Axial Spinal Pain and Post Radiofrequency Ablation Neuritis: A Systematic Review. Curr Pain Headache Rep. 2025;29(1):53. https://doi.org/10.1007/s11916-025-01369-0.</mixed-citation><mixed-citation xml:lang="en">Kaye AD, Brouillette AE, Howe CA, Wajid S, Archer JR, Bartolina R et al. Efficacy of Steroid Facet Joint Injections for Axial Spinal Pain and Post Radiofrequency Ablation Neuritis: A Systematic Review. Curr Pain Headache Rep. 2025;29(1):53. https://doi.org/10.1007/s11916-025-01369-0.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Steffens D, Maher CG, Pereira LS, Stevens ML, Oliveira VC, Chapple M et al. Prevention of Low Back Pain: A Systematic Review and Meta-analysis. JAMA Intern Med. 2016;176(2):199–208. https://doi.org/10.1001/jamainternmed.2015.7431.</mixed-citation><mixed-citation xml:lang="en">Steffens D, Maher CG, Pereira LS, Stevens ML, Oliveira VC, Chapple M et al. Prevention of Low Back Pain: A Systematic Review and Meta-analysis. JAMA Intern Med. 2016;176(2):199–208. https://doi.org/10.1001/jamainternmed.2015.7431.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Hernandez-Lucas P, Leirós-Rodríguez R, Lopez-Barreiro J, García-Soidán JL. Is the combination of exercise therapy and health education more effective than usual medical care in the prevention of non-specific back pain? A systematic review with meta-analysis. Ann Med. 2022;54(1):3107–3116. https://doi.org/10.1080/07853890.2022.2140453.</mixed-citation><mixed-citation xml:lang="en">Hernandez-Lucas P, Leirós-Rodríguez R, Lopez-Barreiro J, García-Soidán JL. Is the combination of exercise therapy and health education more effective than usual medical care in the prevention of non-specific back pain? A systematic review with meta-analysis. Ann Med. 2022;54(1):3107–3116. https://doi.org/10.1080/07853890.2022.2140453.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
